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Hypothalamic orexin/hypocretin (orx/hcrt) neurons
regulate energy balance, wakefulness, and reward;
their loss produces narcolepsy and weight gain.
Glucose can lower the activity of orx/hcrt cells, but
whether other dietary macronutrients have similar
effects is unclear. We show that orx/hcrt cells are
stimulated by nutritionally relevant mixtures of amino
acids (AAs), both in brain slice patch-clamp experi-
ments, and in c-Fos expression assays following
central or peripheral administration of AAs to mice
in vivo. Physiological mixtures of AAs electrically
excited orx/hcrt cells through a dual mechanism
involving inhibition of KATP channels and activation
of system-A amino acid transporters. Nonessential
AAs were more potent in activating orx/hcrt cells
than essential AAs. Moreover, the presence of phys-
iological concentrations of AAs suppressed the
glucose responses of orx/hcrt cells. These results
suggest a new mechanism of hypothalamic integra-
tion of macronutrient signals and imply that orx/
hcrt cells sense macronutrient balance, rather than
net energy value, in extracellular fluid.
INTRODUCTION
Animal and human health depends on detection of changes in
body energy levels by neural circuits coordinating appropriate
adaptive responses. A typical change in energy levels comes
from meals composed of macronutrient mixtures that are
consumed either simultaneously or in a sequence. The nutritional
composition of meals, e.g., protein:carbohydrate ratio, has long
been recognized to affect the levels of arousal and attention
(Spring et al., 1987; Fischer et al., 2002). However, while certain
specialized neurons are known to sense individual nutrients such
as glucose (Levin et al., 2004), it remains unclear how typical
dietary combinations of nutrients affect energy balance-regu-
lating neurocircuits.616 Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc.The central orexin/hypocretin (orx/hcrt) network is critical for
regulating arousal, feeding, reward-seeking, and autonomic
function (de Lecea et al., 2006; Sakurai, 2007; Kuwaki, 2011).
Orexins/hypocretins are peptide transmitters that in mammalian
brains are produced exclusively by a small group of cells
located in the lateral hypothalamic area (de Lecea et al., 1998;
Sakurai et al., 1998). From this restricted location, orx/hcrt
neurons project widely to innervate most of the brain, with major
inputs to arousal and reward centers, where orx/hcrt peptides
are released and act on two specific G protein-coupled recep-
tors (Sakurai et al., 1998; Peyron et al., 1998). The firing of orx/
hcrt neurons promotes wakefulness (Adamantidis et al., 2007)
and is so critical for sustaining normal consciousness that
loss of orx/hcrt cells causes narcolepsy (Hara et al., 2001;
Nishino et al., 2000; Thannickal et al., 2000). Orx/hcrt cells
are also thought to stimulate feeding and reward-seeking
behavior (Boutrel et al., 2005; Harris et al., 2005; Sakurai
et al., 1998), while their destruction inhibits fasting-induced
foraging in mice (Mieda et al., 2004; Yamanaka et al., 2003).
Furthermore, orx/hcrt signaling is involved in autonomic func-
tion and peripheral energy balance (reviewed in Karnani and
Burdakov, 2011; Kuwaki, 2011), and both patients with narco-
lepsy and mice with experimentally destroyed orx/hcrt cells
have significantly increased body weights (Hara et al., 2001;
Nishino et al., 2001).
Orx/hcrt neurons are thought to form a dynamic link between
these vital functions and body energy status, for example, by ex-
hibiting specialized inhibitory responses to key indicators of
energy levels such as glucose and leptin (Diano et al., 2003;
Williams et al., 2008; Yamanaka et al., 2003). However, it remains
unknown how their sensing capabilities extend to the other
major macronutrients, such as amino acids (AAs) and fatty acids
(FAs), or to typical dietary mixtures of macronutrients. Studies
correlating transmitter release with changes in dietary intake
of protein suggest that the lateral hypothalamus and medial
hypothalamus show different responses to protein diets (White
et al., 2003), but the cellular mechanisms are unknown. At the
molecular level, hypothalamic AA sensing has been proposed
to involve enzymes such as the mammalian target of rapamycin
(mTOR) (Cota et al., 2006), but the importance of this pathway
in regulating the activity of orx/hcrt neurons is not understood.
In turn, although hypothalamic FA sensing is thought to be
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of FAs on orx/hcrt cells remain unclear.
Here, we examine the responses of identified orx/hcrt cells to
physiological mixtures of macronutrients. We demonstrate that
orx/hcrt neurons exhibit novel excitatory responses to physio-
logically and nutritionally relevant mixtures of AAs, both in
reduced brain-slice preparations, and during peripheral or
central administration of AAs to mice in vivo. We determine
the cellular mechanisms contributing to these unexpected
responses. Furthermore, we show that the glucose and AA
signals are integrated nonlinearly in favor of AA-induced excita-
tion. In contrast, we did not find evidence that FAs directly
regulate the firing of orx/hcrt cells. Our data suggest a new
nutrient-specificmodel for dietary regulation of orx/hcrt neurons.
RESULTS
Nutritionally Relevant Mixes of Amino Acids Excite
orx/hcrt Neurons In Situ
To test whether the activity of orx/hcrt cells is modulated by die-
tary amino acids (AAs), we first used a mixture of amino acids
(‘‘AA mix’’; see Table S1 available online) based on microdialysis
samples from the rat hypothalamus (Choi et al., 1999). Whole-
cell patch-clamp recording showed that orx/hcrt cells depolar-
ized and increased their firing frequency in response to the AA
mix (Figure 1A; all statistics are given in the figure legends unless
stated otherwise). The latency of response onset was 66 ± 5 s
(n = 25). This response was unaffected by blockers of ionotropic
glutamate, GABA, and glycine receptors (Figure 1B), or by
blockade of spike-dependent synaptic transmission with tetro-
dotoxin (Figure 1C). We did not observe such AA responses in
neighboring lateral hypothalamic GAD65 neurons (Figures 1D
and 1F; see Experimental Procedures), or in cortical pyramidal
cells (Figures 1E and 1F).
We also tested whether orx/hcrt cells are modulated by transi-
tions between different physiological levels of AAs. For this, we
used a mixture of AAs with approximately 56% lower total
concentration than the AA mix above (‘‘low AA’’, see Table S1),
which was also based on microdialysis samples from rat brain
(Currie et al., 1995). By itself, switching from zero AA to the low
AA solution induced a depolarization of 8.7 ± 0.4 mV (n = 6,
p < 0.02). Switching between low and control AA levels robustly
and reversibly altered the membrane potential and firing of
orx/hcrt cells (6.1 ± 1.2 mV depolarization, n = 8, p < 0.01, Fig-
ure 1G). Measuring the dose-response relationship of AA-
induced excitation of orx/hcrt cells revealed steep sensitivity
within the physiological range of AA levels (Figure 1G). In addition
to whole-cell recordings, we also observed reliable stimulation
of orx/hcrt cell firing by physiological AA concentrations using
the noninvasive cell-attached recording configuration (Fig-
ure 1H), further demonstrating that it is a robust physiological
phenomenon.
Activation of orx/hcrt Cells after Gavage of Amino Acids
In Vivo
Previous data in rats show that gavage of a nutritionally relevant
AA mix causes an increase in AA concentrations in the lateral
hypothalamus, which becomes apparent 20–40min after gavageand may persist for several hours (Choi et al., 1999). To test
whether such peripheral administration of AAs can activate
orx/hcrt neurons in vivo, we intragastrically gavaged mice with
an AA mixture that mimics the composition of egg-white
albumin (based on Choi et al., 1999), or with the same volume
of vehicle (deionized water), and looked at changes in c-Fos
expression in immunohistochemically identified orx/hcrt neurons
3 hr later (see Experimental Procedures). The number of c-Fos-
positive orx/hcrt neurons in AA-gavaged animals was signifi-
cantly greater than in vehicle-gavaged animals (Figures 2A and
2B), consistent with the data showing that gavaged AAs reach
the lateral hypothalamus (Choi et al., 1999), and activate orx/
hcrt cells (Figure 1).
We also tested whether the AA gavage can produce behav-
ioral effects associated with activation of the orx/hcrt system.
Based on previous reports that orx/hcrt promotes locomotor
activity (Hagan et al., 1999), we used locomotion (beam-breaks,
see Experimental Procedures) as a behavioral readout of orx/
hcrt tone. Note that the procedures necessary for this experi-
ment (prefasting and gavage) are themselves expected to
stimulate orx/hcrt receptors (see Experimental Procedures).
Thus, to avoid confounding ‘‘ceiling’’ effects, the competitive
orx/hcrt receptor antagonist SB-334867 was given simulta-
neously with gavage (see Experimental Procedures and Fig-
ure S1 for full considerations and experimental details). Indeed,
in the absence of SB-334867, gavage composition did not signif-
icantly affect locomotor activity, likely attributed to a ceiling
effect (see Experimental Procedures and Figure S1). However,
when the background occupancy of orx/hcrt receptors was low-
ered with SB-334867, AA gavage (but not vehicle gavage) signif-
icantly increased locomotor activity and accelerated recovery
from the antagonist-induced depression of locomotion (Figures
2C and 2D). This is consistent with the idea that the activation
of orx/hcrt cells by AA gavage (Figures 2A and 2B) increases
orx/hcrt release and thereby displaces the competitive antago-
nist from orx/hcrt receptors, while in vehicle-gavaged animals,
this additional orx/hcrt release is absent, allowing the antagonist
to depress locomotion for longer. The AA-induced increase in
locomotor activity was transient (see Figures 2C and 2D), consis-
tent with the transient [AA] elevation resulting from AA gavage
(Choi et al., 1999), and with the reversible nature of AA effects
on orx/hcrt cells (Figure 1).
Effects of Individual Amino Acids
To explore whether orx/hcrt cells are more sensitive to particular
AAs, we first examined their membrane current responses to
individual AAs applied at high concentration (5 mM). In this
voltage-clamp assay, nonessential AAs elicited large responses,
with a relative potency order glycine > aspartate > cysteine >
alanine > serine > asparagine > proline > glutamine, while essen-
tial AAs were much less effective (Figures 3A and 3B). Because
leucine has been suggested previously to be sensed in the
hypothalamus (Cota et al., 2006), we investigated its effect
across a broad concentration range in comparison with alanine
(Figure 3C). Across all concentrations tested, leucine (0.02–
10 mM) did not induce any detectable membrane currents,
whereas alanine dose-dependently stimulated currents with an
EC50 of 3.19 mM (Figure 3C).Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 617
Figure 1. Effects of Physiological Amino Acid Mixes on the Membrane Potential of orx/hcrt and Other Central Neurons
(A) Effect of ‘‘AAmix’’ (see Table S1) on orx/hcrt cells (n = 25). Membrane potential during AA application (39.4 ± 0.8mV) was higher than preapplication (51.8 ±
0.6 mV, p < 0.0001) or postapplication (51.0 ± 1.1 mV, p < 0.0001).
(B) Same with synaptic blockers (see Experimental Procedures, n = 5). Membrane potential during AA application (40.1 ± 1.1 mV) was depolarized relative to
preapplication (50.4 ± 0.5 mV, p < 0.002) or postapplication (48.0 ± 1.6 mV, p < 0.02).
(C) Same as A with tetrodotoxin (0.5 mM, n = 5). Membrane potential during AA application (42.2 ± 1.4 mV) was higher than preapplication (53.5 ± 0.8 mV,
p < 0.002) or postapplication (51.2 ± 1.0 mV, p < 0.001).
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under more physiological conditions, we performed two further
experiments. First, we examined membrane potential effects of
low concentrations of different AA mixtures. When we mixed
AAs together at 100 mM each, and examined their effects in the
absence of synaptic blockers (some AAs were omitted to avoid
activation of synaptic receptors, see Experimental Procedures),
we found that nonessential AA mix induced larger depolarization
that essential AA mix (Figure 3D). When the AAs were instead
mixed together at physiological concentrations measured in
the brain (‘‘AA mix’’, Table S1), and their effects examined in
synaptic blockers, the nonessential AA mix also produced
greater responses (Figure 3D). Second, we infused 5mM leucine
(essential), 5 mM asparagine (nonessential), or vehicle into the
lateral hypothalamus of live mice, and examined c-Fos expres-
sion in orx/hcrt cells an hour later (see Experimental Procedures).
Consistent with in vitro data, asparagine significantly increased
the percentage of orx/hcrt neurons expressing c-Fos compared
with either vehicle or leucine (Figures 3E and 3F).
Mechanisms of Amino Acid Sensing: Membrane
Pathways
To explore the mechanisms of membrane excitation induced by
the nutritionally relevant AA mix (Figure 1), we next performed
whole-cell voltage-clamp recordings. Examining membrane
current-voltage relationships before and during stimulation
with the physiological AA mix showed that AAs suppressed
a current with a reversal potential of 99.2 ± 7.1 mV (Figure 4A),
suggesting a closure of K+ channels (EK = –107.6 mV with our
solutions). We reasoned that ATP-sensitive K+ channels (KATP)
are attractive candidates since they are closed by increased
intracellular ATP (Ashcroft, 1988). Indeed, blocking KATP
channels with tolbutamide substantially diminished AA-induced
depolarization and current (Figures 4B and 4D). However, some
membrane depolarization remained (Figure 4B), suggesting
additional, tolbutamide-insensitive, mechanism(s).
To explore these additional pathways, we examined the
biophysical and pharmacological properties of AA responses in
the presence of tolbutamide. Under these conditions, AAs acti-
vated a net inward current, which did not reverse within the
membrane potential range we examined (Figure 4B). Because
such current-voltage characteristics resemble those of electro-
genic amino acid transporters, whose activity depolarizes cell
membranes due to cotransport of Na+ ions (Mackenzie and
Erickson, 2004; Mackenzie et al., 2003), we tested the effects
of different blockers of these membrane transporters. The excit-
atory amino acid transporter blocker TBOA did not affect the(D) Effect of ‘‘AA mix’’ on non-orx/hcrt lateral hypothalamic neurons expressin
AA application (46.6 ± 1.2 mV) was not different from preapplication (48.8 ± 1
(E) Effect of ‘‘AA mix’’ on neurons from secondary somatosensory cortex layer 2-
different from preapplication (49.6 ± 0.6 mV, p > 0.3) or postapplication (48.8
(F) Depolarization (means ± SEM) caused by the AA mix in different conditions, e
(G) Left, effect of switching from ‘‘low AA mix’’ to ‘‘AA mix’’ (see Table S1) on orx
induced depolarization. Total concentration of AA mix was changed while prop
Experimental Procedures) = 438.2 mM (equivalent to 0.66-fold of ‘‘AA mix’’ in Tab
(H) Effects of AAs in cell-attached recording mode (left, frequency histogram; right
0.3 Hz, p < 0.001).tolbutamide-insensitive remnant of the AA response (Figure 4D).
In contrast, the system-A transporter inhibitor meAIB completely
abolished it (Figures 4C and 4D). Together, these data imply that
membrane depolarization induced by AAs is explained by
a decrease in hyperpolarizing activity of tolbutamide-sensitive
KATP channels and a concurrent increase in the depolarizing
activity of meAIB-sensitive system-A transporters.
Mechanisms of Amino Acid Sensing: Intracellular
Pathways
We next examined the intracellular signaling pathways involved
in AA sensing. We focused on ATP-generating pathways poten-
tially coupled to KATP channels, and on mTOR-requiring path-
ways, which may mediate AA sensing in other hypothalamic
regions (Cota et al., 2006). Suppressing mitochondrial ATP
production with 2 mM oligomycin reduced, but did not abolish,
the effect of AAs on the membrane potential and current (Figures
5A and 5C). The current-voltage relationship of the oligomycin-
insensitive component of the AA response (Figure 5A) was
similar to the tolbutamide-insensitive component (Figure 4B),
suggesting that the two drugs block the same part of the
response. The simplest explanation for this is that mitochon-
dria-derived ATP is required to drive the KATP -dependent
component of the AA response. In contrast, blocking mTOR
activity with 1 mM rapamycin did not affect AA-induced depolar-
ization or current (n = 5, Figure 5B,C), suggesting that mTOR is
not critical for AA sensing in orx/hcrt neurons, consistent with
the lack of effect of leucine (anmTOR stimulator) on orx/hcrt cells
(Figures 3C, 3E, and 3F).
Effects of Combinations of Amino Acids and Glucose
There is evidence suggesting that brain levels of both glucose
and AAs may rise after a meal (Choi et al., 1999, 2000; Silver
and Erecinska, 1994). We therefore examined the effects of
simultaneous application of glucose and AAs. We expected
that when AAs and glucose are applied together, the two
responses would either cancel out or produce a net inhibition
because the inhibitory current induced by glucose (e.g., see Fig-
ure 7A) was generally larger than the excitatory current induced
by AAs (e.g., see Figure 4A). Surprisingly, application of AAs
mixed with concentrations of glucose that were similar or greater
thanmaximal physiological levels in the brain (5–10mM glucose,
see Routh, 2002) produced potent depolarization and excitation,
even though glucose alone produced its typical hyperpolariza-
tion on the same cell (Figure 6A). The depolarizing direction of
these responses persisted even when the AA concentration in
the combined stimulus was reduced 2- or 4-fold (Figure 6B).g GAD65 (n = 7, see Experimental Procedures). Membrane potential during
.0 mV, p > 0.15) or postapplication (47.5 ± 1.7 mV, p > 0.6).
4 (n = 7). Membrane potential during AA application (49.1 ± 0.8 mV) was not
± 1.1 mV, p > 0.8).
voked from the same baseline of 50 mV (*** = p < 0.001; n.s. = p = 0.24).
/hcrt cells (n = 6, quantified in F). Right, dose-response (means ± SEM) of AA-
ortions of AAs were kept same as in ‘‘AA mix’’ in Table S1. EC50 value (see
le S1).
, raw trace, n = 6). Firing rate was higher in AA (6.6 ± 0.5 Hz) than in low AA (3.0 ±
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Figure 2. Effects of Peripheral Administration of
Amino Acids on orx/hcrt Neurons and Locomotion
(A) Photomicrographs of immunolabeled orx/hcrt cells
(green) and c-Fos (red) from mice gavaged with vehicle
(top panels) or AAs (bottom panels). White arrowheads
indicate orx/hcrt-positive cells (stained green), and white
arrows show double-labeled orx/hcrt and c-Fos-positive
cells displaying green cytoplasm and red nuclei. Scale
bars are 200 mm for left panels and 50 mm for right panels.
(B) Percentage of orx/hcrt-positive cells that were also
c-Fos-positive after infusion of vehicle or AAs (means ±
SEM). *p < 0.05 by one way ANOVA. The numbers of
orx/hcrt cells counted were: vehicle, 2662 (of which 1183
were c-Fos+); AAs, 2366 (of which 1319 were c-Fos+).
Four animals were analyzed in each group.
(C) Locomotor activity time course in three groups of
mice: vehicle gavaged and vehicle i.p. (‘‘control’’, black),
vehicle gavaged and SB-334867 i.p. (‘‘SB’’, red), and
AA gavaged and SB-334867 i.p. (‘‘SB+AA’’, green).
Repeated-measures ANOVA showed that there is
a significant difference between SB+AA and SB groups
(F(1,14) = 3.26, p < 0.01), and between control and SB
groups (F(1,14) = 2.18, p < 0.05). Eight animals were
analyzed per group. White-gray bar alongside the x axis
marks the light-dark cycle (see Experimental Procedures).
Values are means ± SEM.
(D) Locomotor activity (means ± SEM, from the same
experiment shown in C), grouped to compare specific time
points (indicated on the x axis). *p < 0.05 by one way
ANOVA followed by Bonferroni post hoc test.
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Figure 3. Effects of Individual Amino Acids on orx/
hcrt Cells In Situ
(A) Examples of membrane currents induced by 5 mM AA
(holding potential = 60 mV).
(B) Comparison of membrane currents (means ± SEM)
induced by different AAs at same holding potential
of 60 mV. n R 3 for each amino acid, all responses to
nAAs are significant (p < 0.05); none of responses to
eAAs are significant (p > 0.1).
(C) Dose-response of currents (means ± SEM) induced by
alanine and leucine from same holding potential (60 mV).
Alanine EC50 was 3.19 mM. Leucine currents were not
different from zero at all concentrations shown (p > 0.3
for all).
(D) Top, effect of mixtures of essential AAs (eAAs) and
nonessential AAs (nAAs) on membrane potential (100 mM
each AA, see Experimental Procedures). The same
baseline potential of –50 mV was imposed by sustained
current injection. eAAs produced 3.2 ± 1.0 mV depolar-
ization, nAAs produced 9.0 ± 1.5 mV depolarization, n = 4
for each, p < 0.01. Bottom, effect of mixes of physiological
concentrations of nAAs (physiol-nAAs) and eAAs (physiol-
eAAs) on membrane potential studied in the same cell
(n = 7). The same prestimulation potential of –50 mV was
imposed by sustained current injection. nAAs produced
6.0 ± 0.5mV depolarization (significantly greater than zero,
p < 0.0001), eAAs produced 1.8 ± 0.8 mV depolarization
(not significantly greater than zero, p > 0.05); nAA effect
was significantly larger than eAA (p < 0.002).
(E) Photomicrographs of double-immunostained sections
from animals hypothalamically infused with vehicle,
leucine, or asparagine. Black arrowheads indicate orx/
hcrt-positive cells with their cytoplasm stained brown, and
black arrows show double-labeled orx/hcrt and c-Fos-
positive cells displaying brown cytoplasm and black
nuclei. Scale bar: 40 mm.
(F) Percentage of orx/hcrt-positive neurons (means ±SEM)
that were also c-Fos-positive after intrahypothalamic
infusion of vehicle, leucine (Leu; 5 mM) or asparagine
(Asn; 5 mM). ***p < 0.0001 significantly different from
other groups (one-way ANOVA followed by Tukey post
hoc tests). The numbers of orx/hcrt cells counted were:
vehicle 2085 (of which 384 were c-Fos+); asparagine 1087
(of which 544 were c-Fos+), leucine 1150 (of which 206
were c-Fos+). Four animals were analyzed in each group.
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not sum linearly, but become biased toward the AA response.
Indeed, during coapplication of glucose and AAs, the net change
in membrane current resembled that caused by AAs alone
(Figures 6C and 6D).
To examine whether this is because the AAs influence the
glucose response, we looked at glucose responses with and
without AAs in the bath solution. We found that glucose-acti-
vated current was significantly suppressed (3- to 4-fold) in
the presence of AAs, for both large (1 / 5 mM) and small
(0.5/ 2.5 mM) changes in [glucose] (Figure 7A). To investigate
whether changes in intracellular energy metabolism could be
involved in such changes in glucose response magnitude, we
next examined glucose responses in the presence of differentconcentrations of extracellular pyruvate. This is expected to
mimic the effects of AAs downstream of system-A transporters,
because (1) the catabolic pathways of many AAs involve
pyruvate production (Stryer, 1999), and (2) exogenously applied
pyruvate is able to enter neurons, increase ATP levels, and drive
ATP-dependent processes (Cruz et al., 2001; Tarasenko et al.,
2006). We found that pyruvate dose-dependently reduced the
magnitude of glucose-activated current (Figure 7B).
The suppression of glucose response by AAs presumably
accounts for the excitatory response seen when AAs and
glucose are applied simultaneously (Figure 6), or when AAs are
applied on the background of elevated glucose (Figure 7C).
However, consistent with the observation that the glucose
current was not completely blocked by physiological levelsNeuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 621
Figure 4. Pharmacological and Biophysical Analysis of Membrane
Events Involved in Amino Acid Sensing in orx/hcrt Cells
(A) Effect of AA mix on the membrane potential (top) and membrane I-V rela-
tionship (bottom left). Bottom right: net current inhibited by AAs (current before
Neuron
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pre-elevated AAs still produced consistent hyperpolarizing
responses (Figure 7D). Thus, during sequential application of
glucose and AAs, different responsesmay be produced depend-
ing on the relative order of the two stimuli.
Effects of Fatty Acids
In addition to glucose and amino acids, the third major group of
macronutrients that are sensed by the brain as signals of energy
status are fatty acids (Lam et al., 2005). We examined the effects
of a mixture of three common fatty acids (FA mix, composition
given in Experimental Procedures), which were previously
reported to modulate firing of neurochemically undefined hypo-
thalamic neurons (Oomura et al., 1975; Wang et al., 2006). To
elicit maximum responses, our FA mix contained higher FA
concentrations than those reported in the brain in vivo (Phillis
et al., 1999). We found no evidence for FA-elicited changes in
membrane potential or voltage ramps (Figures 8A and 8B,
n = 7). We also carried out cell-attached recordings while
applying a 3x concentrated FA mix. Firing frequency did not
change significantly during FA application (baseline firing rate,
4.0 ± 0.5 Hz; during FA application, 4.8 ± 1.2 Hz; n = 4;
p = 0.48; data not shown). Furthermore, coapplication of FAs
with either 5 mM glucose (n = 4) or AA mix (n = 5) or both
(n = 5) did not change the typical responses to these nutrient
mixtures (Figure 8C). This suggests that under our experimental
conditions, FAs do not directly modulate the firing of orx/hcrt
cells.
DISCUSSION
Actions of Dietary Amino Acids on orx/hcrt Circuits
Despite the importance of dietary timing and composition for
healthy body weight and sleep-wake cycles (Flier, 2004;
Kohsaka et al., 2007), the effects of typical dietary nutrient
mixtures on specific neurons regulating metabolic health are
poorly understood. Our study uncovers several features of
macronutrient interactions with cells that act as key regulators
of energy balance. First, the orx/hcrt cells were directly stimu-
lated by nutritionally relevant mixtures of dietary AA mixtures,
both in vitro (Figure 1) and in vivo (Figures 2A and 2B). Peripheral
administration of AAs produced locomotor effects consistent
with orx/hcrt release (Figure 2C). Second, our data show that
the stimulatory effects of AAs on orx/hcrt cell membrane involve
an increase in the depolarizing activity of system-A AA trans-
porters, and a concurrent reduction in the hyperpolarizingAA stimulation minus current during AA stimulation), n = 16, means are shown
in black and SEMs in pink.
(B) Same experiment as in (A), but in the presence of 300 mM tolbutamide (Tb).
The net current (bottom right graph) was calculated as current during AA
stimulation minus current before AA stimulation (i.e., AAs-activated current)
(n = 12).
(C) Same experiment as in (B), but in the presence of 300 mM tolbutamide and
10 mM meAIB (n = 11).
(D) Quantification of membrane depolarization (means ± SEM) in the presence
and absence of drugs (n = 25 for control, 9 for Tb, 5 for Tb+TBOA, 9 for
Tb+meAIB). *** = p < 0.001, n.s. = not significant (p > 0.3).
Figure 6. Effects of Coapplication of Amino Acids and Glucose on
orx/hcrt Neurons
(A) Effect of AA mix and glucose (G, 10 mM) applied together and separately
(n = 4).
(B) Effect of scaling down the levels of AA mix in the mixture of AAs and 5 mM
glucose (n = 3).
(C) Effects of combined application of glucose (5 mM) and AA mix on the
membrane I-V relationship (n = 4).
(D) Net current inhibited by 5 mM glucose and AAs (AAG) applied together
(means ± SEM of 4 cells, calculated from recordings such as that shown in C).Figure 5. Pharmacological Analysis of Intracellular Events Involved
in Amino Acid Sensing by orx/hcrt Cells
(A) Same experiment as in Figure 4A, but performed in the presence of 2 mM
oligomycin (n = 10).
(B) Same experiment in the presence of 1 mM rapamycin (n = 5).
(C) Quantification of membrane depolarization (means ± SEM) in the presence
of rapamycin and oligomycin *** = p < 0.0001, n.s. = p > 0.5.
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involvement of the system-A transporters, which prefer nones-
sential AAs (Mackenzie and Erickson, 2004), orx/hcrt cells
were more potently stimulated by nonessential AAs in vitro and
in vivo (Figure 3). Third, the excitatory influence of AAs on
orx/hcrt cells summed nonlinearly with the previously reportedNeuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 623
Figure 7. Modulation of Glucose Response by Amino Acids
(A) Top trace, experimental protocol used to obtain data in middle and bottom traces. Middle, net current elicited by a switch from 0.5 to 2.5 mM glucose in
the presence and absence AAs (n = 5 cells in each group, means are shown in black and SEMs in gray. Bottom, net current elicited by a switch from 1 to 5 mM
glucose in the presence and absence AAs (n = 5 cells in each group, means are shown in black and SEMs in gray. At50 mV, currents elicited by both changes
in [glucose] were significantly lower in the presence of AAs than in the absence of AAs (p < 0.01 for each group).
(B) Effects of glucose in the presence of pyruvate (pyr, applied extracellularly). Top traces, examples of membrane potential responses to a switch between 1 and
5 mM glucose. Bottom graph, net current elicited by a switch from 1 to 5 mM glucose. For clarity, only averaged currents are shown (n > 4 for each pyruvate
concentration). At 50 mV, the current was smaller in 1 mM pyruvate (23.0 ± 11.9 pA, n = 4) than in 0 mM pyruvate (83.3 ± 12.7 pA, n = 6), p < 0.02.
(C) Typical membrane potential responses to glucose and AAs persist during sequential application, first glucose (increase from 1 to 5 mM) then AAs on
background of 5 mM glucose), n = 8.
(D) Same as in (C), but reversing the sequence of application, n = 9.
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This is probably due to the suppression of the glucose response
by AAs, and/or their metabolic derivatives (Figure 6). Because
physiological AA fluctuations in the brain occur within a smaller
concentration range than those of glucose (Choi et al., 1999,
2000; Silver and Erecinska, 1994), it is possible that the suppres-
sion of glucose response by AAs may serve to amplify the rela-
tive influence of AAs on the orx/hcrt neurons.
Implications for Sensing of Macronutrient Balance
Recently, two hypotheses were proposed to explain how the AA
composition of the extracellular space could be converted into624 Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc.appropriate changes in brain activity. One envisages sensing
of essential AAs by deacylated tRNA in the piriform cortex,
based on the observation that blocking tRNA synthetases of
essential AAs in this region induces feeding behavior similar to
that caused by essential AA deficiency (Hao et al., 2005). Another
hypothesis involves sensing of leucine (an essential AA) by an
mTOR-related pathway in the mediobasal hypothalamus (Blouet
et al., 2009; Cota et al., 2006). Both of these mechanisms are
selective for essential AAs, unlike the mechanism described in
our study, which is more sensitive to nonessential AAs. In terms
of body function, essential AA levels may seem to be more
critical to detect, because they cannot be made in the body
Figure 8. Effect of Fatty Acids on orx/hcrt Neurons
(A) Effects of FAs on the membrane potential, n = 8. In FA, the membrane
potential was 49 ± 2 mV; not different from baseline (46 ± 2 mV, n = 5, p >
0.1) or washout (47.1 ± 1.1 mV, n = 5, p > 0.3).
(B) Effects of FAs on the membrane current (shown as net FA-activated
current, means in black and SEM in gray), n = 7.
(C) Effects of coapplying FAs with either glucose (G, n = 4), AAs (n = 5), or both
(n = 5). The amplitudes of responses with FAs did not differ from those without
FAs: FA+AA, 11.7 ± 2.1 mV depolarization v AA, 12.6 ± 0.7 (p > 0.5, n = 5 and
25, respectively); FA+glucose, 15.1 ± 2.1 mV hyperpolarization v glucose,
18.2 ± 1.0 mV (p > 0.18, n = 4 and 5, respectively); FA+AA+glucose, 12.0 ±
2.0 mV depolarization v AA+glucose, 10.5 ± 0. 9 mV (p > 0.5, n = 5 for both).
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noteworthy that essential and nonessential AAs can compete
with each other for entry through the blood-brain barrier (Olden-
dorf and Szabo, 1976), and thus a rise in nonessential AA levels in
the brain may signal a fall in essential AA levels in the blood.
Another physiological situation that may, potentially, benefit
from increased stimulation of orx/hcrt neurons by AAs is pro-
longed starvation, where a rise in extracellular AA levels occurs
as proteins are broken down to AAs for fuel (Adibi, 1968; Felig
et al., 1969).More fundamentally, our data suggest that orx/hcrt neurons
are under ‘‘push-pull’’ control by glucose and AAs, and that
nutrient mixtures dominated by glucose would suppress the
orx/hcrt system,while nutrientmixtures dominated byAAswould
increase its activity. Interestingly, there is accumulating evidence
that underactivity and overactivity of the orx/hcrt system may
lead to depression and anxiety, respectively (Boutrel et al.,
2005; Brundin et al., 2007; Ito et al., 2008; Suzuki et al., 2005).
While a definitive investigation of behavioral effects is beyond
the scope of the present study, it is noteworthy that some
existing psychological analyses are consistent with our cellular
data. For example, protein-rich meals have been reported to be
more effective at promoting cognitive arousal than carbohy-
drate-rich meals (Fischer et al., 2002; Spring et al., 1982-1983).
In summary, our data show that the activity in the orx/hcrt
system is regulated bymacronutrient balance, rather than simply
by the caloric content of the diet. We propose that the distinct
effects of different macronutrients on orx/hcrt cells may allow
these neurons to translate different diets into different patterns
of activity in their widespread projection targets.
EXPERIMENTAL PROCEDURES
Electrophysiological Recordings in Acute Mouse Brain Slices
Preparation of Living Brain Tissue
Animal procedures were performed according to the Animals (Scientific
Procedures) Act, 1986 (UK). Transgenic orx/hcrt-eGFP mice were used to
identify and study orx/hcrt neurons in electrophysiological experiments, as
previously described (Williams et al., 2007, 2008). These mice express eGFP
under the control of the prepro-orexin promoter, resulting in highly specific tar-
geting of eGFP only to orx/hcrt cells (Burdakov et al., 2006; Yamanaka et al.,
2003).
For lateral hypothalamic control experiments shown in Figure 1D, we used
GAD65-GFP mice, which were of C57BL/6 background and expressed GFP
gene fused to the first or third exon of the GAD65 gene; these mice express
GFP exclusively in GABAergic GAD65-containing neurons, as previously char-
acterized (Bali et al., 2005; Lo´pez-Bendito et al., 2004).
Miceweremaintained on a 12hr light:dark cycle (lights onat 0800 hr) and had
free access to food and water. Coronal slices (250 mm thick) containing the
lateral hypothalamus were prepared from 13- to 29-day-old animals. Experi-
ments in Figures 1G, 7C, and 7D were replicated in adult mice (37–64 days
old). Mice were killed by cervical dislocation during the light phase and rapidly
decapitated. Brains were quickly removed and placed into ice-cold sectioning
solution. A block of brain tissuewas glued to the stage of aCampdenVibroslice
for slicing while immersed in ice-cold sectioning solution. After a 1 hr recovery
period at 35C in ACSF, slices were used for recordings within 8 hr.
Basic Solutions
ACSF was continuously gassed with 95% O2 and 5% CO2 and contained (in
mM): 125 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.2 NaH2PO4, 21 NaHCO3, and
1 glucose (except where indicated otherwise). Sectioning solution contained
(in mM): 95 NaCl, 1.8 KCl, 1.2 CaCl2, 26 NaHCO3, 1.2 KH2PO4, 7 MgSO4,
50 sucrose, and 15 glucose. Two types of intracellular (pipette) solutions
were used. ‘‘High-Cl’’ pipette solution contained (in mM): 130 KCl,
0.1 EGTA, 10 HEPES, 5 K2ATP, 1 NaCl, 2 MgCl2 (pH 7.3) with KOH. ‘‘Low-
Cl’’ pipette solution contained (in mM): 120 K-gluconate, 10 KCl, 0.1 EGTA,
10 HEPES, 5 K2ATP, 1 NaCl, 2 MgCl2 (pH 7.3) with KOH. Liquid junction
potential for the low-Cl solution was estimated to be 10 mV and has not
been subtracted from the measurements. The low-Cl solution, which mimics
the ionic composition in a typical central neuron, was used in all experiments
except those in Figures 3A–3C (where we used high-Cl solution) and Figure 1H
(where we used ACSF).
Nutrient Mixtures
All AAs used were L-isoforms and glucose was D-(+)-glucose. The concen-
trations of AAs in the control and ‘‘low’’ AA mixes are given in Table S1Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 625
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examined by ion-exchange chromatography followed by ninhydrin analysis
(Department of Biochemistry Analytical Facility, University of Cambridge),
where threshold for detection was 0.5 mM. No GABA or glutamate contamina-
tion was detected and glycine concentration was within 10% of the intended
value. Classification of amino acids as essential or nonessential in Figure 3B
was based on Gietzen and Rogers (2006). In the upper panel of Figure 3D,
we omitted cysteine because it is toxic and not found in CSF (Choi et al.,
1999; Nishimura et al., 1995), glutamate to avoid excitation through glutamate
receptors, and glycine because at high concentrations it may modulate
orx/hcrt neurons through glycine receptors (Karnani et al., 2010). In the upper
panel of Figure 3D, other AAs listed in Table S1 were present in 100 mM
concentration making the total concentration for essential AA mix 1.1 mM,
and nonessential AA mix 0.6 mM. In the lower panel of Figure 3D, the concen-
trations for AAs were from ‘‘AA mix’’ in Table S1. ‘‘FA mix’’ contained (in mM):
5 oleic acid, 5.4 palmitic acid, and 1.8 palmitoleic acid (Oomura et al., 1975;
Wang et al., 2006).
Drugs
The following drugs were added to the extracellular solution where indicated:
50 mM (2R)-amino-5-phosphonovaleric acid (AP5), 10 mM 6-cyano-7-nitroqui-
noxaline-2,3-dione (CNQX), 10 mM dizocilpine maleate (MK801), 50 mM
picrotoxin (PiTX), 200 mM DL-threo-b-Benzyloxyaspartic acid (TBOA), 3 mM
strychnine, 1 mM rapamycin, 2 mMoligomycin and 10mMN-(methylamino)iso-
butyric acid (MeAIB), 0.5 mM tetrodotoxin. All drugs were obtained from
Sigma or Tocris (UK). Chemicals were applied extracellularly by bath
superfusion.
Recording and Analysis
Living neurons expressing eGFP were visualized in brain slices using an
Olympus BX50WI upright microscope equipped with oblique illumination
optics, a mercury lamp, and eGFP excitation and emission filters. Somatic
recordings were carried out at 37C using an EPC 10 patch-clamp amplifier
(HEKA Elektronik, Germany). Patch pipettes were made from borosilicate
glass, and their tip-resistances ranged from 3 to 8 MU (3–5 MU with high-Cl
and 5–8 MU with low-Cl pipette solution). Slices were placed in a
submerged-type chamber (volume 2 ml, solution flow rate 2.5 ml/min) and
anchored with a nylon string grid. Only cells with access resistances between
10 and 25 MU were accepted for analysis. In experiments where change in
membrane potential was quantified, all cells were initially held at the same
potential to facilitate comparison (50mVwhen depolarization was quantified,
and 40 mV when hyperpolarization was quantified), by applying a fixed
holding current throughout experiment. Data were sampled and filtered using
Pulse and Patchmaster software (HEKA Elektronik, Germany). Current-voltage
(I-V) relationships were obtained by performing voltage-clamp ramps
from 20 to 130 mV at a rate of 0.1 mV/ms ramp, which is sufficiently slow
to allow leak-like K+ currents to reach steady state at each potential (Meuth
et al., 2003). In cell-attached mode (Figure 1H), the patch pipette was filled
with ACSF and action potential frequency was measured in voltage-clamp
at a command potential under which the holding current is 0 pA (Perkins,
2006). Breaks in some current-clamp traces correspond to moments when
the recording was paused (e.g., to take voltage-clampmeasurements or inject
cell with current for measurement of input resistance). In some current-clamp
experiments (e.g., Figures 1D and 4A) the cells were periodically injected with
hyperpolarizing current pulses to monitor membrane resistance. Statistical
analyses were performed using Origin (Microcal, Northampton, MA) and
Microsoft Excel (Microsoft, Redmond, WA) software. Averaged data are
presented as mean ± SEM. Statistical significance was tested using the
Student’s t test unless indicated otherwise.
The following modified Hill equation was fitted to the data in Figures 1G
and 3C:
V =
Rmax½AAh
ECh50 + ½AAh
where Rmax is the maximal change in membrane potential, EC50 is the concen-
tration that gives half-maximal response, and h is the Hill coefficient. The fit
shown in Figure 1G was obtained with Rmax = 20.4 mV, h = 1.79 and EC50 =
438.2 mM. The fit shown in Figure 3C was obtained with Rmax = 950.6 pA,
h = 2.39, and EC50 = 3.19 mM.626 Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc.Assays of orx/hcrt Activity after Peripheral Administration
of Amino Acids
Intragastric Gavage
Subjects were 14-week-old C57BL/6 male mice (Charles River). The mice
were maintained on a standard 12 hr light-dark cycle (lights on at 0700 hr).
Mice were acclimatized to the gavage procedure for 2 weeks by daily sham
gavage. Foodwas available ad libitum, but to avoid large between-animal vari-
ations inmetabolic state, micewere fasted throughout the experiment, starting
2 hr (at 1700 hr) prior to gavage (1900 hr). Animals were then given either
vehicle gavage (0.4 ml deionized water) or AA gavage (0.4 ml of AAs dissolved
in deionized water, at concentrations described in Table 1 of Choi et al., 1999).
Immunocytochemistry
Three hours after gavage of AA or vehicle solutions (four animals per group),
the animals were anesthetized with ketamine (100 mg/kg i.p), and transcar-
dially perfused with diethylpyrocarbonate (DEPC)-treated 0.9% saline fol-
lowed by phosphate-buffered 10% formalin. Hypothalamic sections (30 mm)
were pretreated in 0.6% H2O2 and washed three times with 0.1 M PBS.
Following a 1 hr incubation in blocking solution (1% BSA in 0.1 M PBS and
0.25% Triton X-100), tissue was gently shaken overnight (4C) in 0.1 M PBS
with rabbit anti-c-Fos (Calbiochem; Nottingham, UK) and goat anti-orexin
(Santa Cruz Biotechnology, Santa Cruz, CA) antibodies (1:10,000; 1:1000;
respectively). On Day 2, tissue was rinsed in 0.1 M PBS and incubated
with secondary antibodies against rabbit (Biotinylated; 1:1000; Stratech;
Newmarket Suffolk, UK; shown in red pseudocolor in Figure 2A) and goat
(Alexa 488, 1:1000; Paisley, UK; shown in green in Figure 2A) in blocking solu-
tion for 2 hr. Next, tissue was shaken in a standard ABC mixture (Vector Labs;
Peterborough, UK) for 1 hr and then processed using a 3,30-Diaminobenzidine
(DAB) kit (Vector Labs; Peterborough, UK). Tissue was finally washed in 0.1 M
PBS, mounted onto slides and coverslipped. Quantification of the proportion
of c-Fos-positive orx/hcrt neurons was performed by an investigator blind
to the experimental conditions, using four to six sections per animal in the
bregma range 1.88 to 1.06 mm, as described in our previous study
(Williams et al., 2011).
Locomotor Activity Assay
Mouse locomotor activity was measured in the x-dimension using a beam-
break monitor in the Comprehensive Lab Animal Monitoring System (CLAMS,
Columbus Instruments) at the animal core facility of the Institute of Metabolic
Science, University of Cambridge. Note that measuring the effect of AA
gavage on locomotion itself unavoidably produces increased orx/hcrt release.
Specifically, this would be caused by the necessary prefasting (which
increases orx/hcrt activity, Cai et al., 2001; Komaki et al., 2001), the stress
and wakefulness induced by gavage in mice (orx/hcrt cells are stress-stimu-
lated, Winsky-Sommerer et al., 2004), and the circadian phase used to
measure locomotion (during which the endogenous activity of orx/hcrt cells
is likely to be high (Estabrooke et al., 2001; Kiyashchenko et al., 2002; Miley-
kovskiy et al., 2005). As expected from such effects, our control experiments
(see Figure S1) indicated that under these conditions, AA gavage described in
(Choi et al., 1999) does not significantly elevate the already-high locomotor
activity, consistent with a ‘‘ceiling’’ effect. To reduce the background occu-
pancy of orx/hcrt receptors, we thus treated the animals with the competitive
orx/hcrt receptor antagonist SB-334867 (given i.p. at the same time as
gavage). This antagonist has a higher affinity for OX1/HCRTR1 receptor
than for OX2/HCRTR2 receptor, but at higher concentrations antagonizes
orx/hcrt binding to both receptor subtypes (Smart et al., 2001). We used
a single high dose of SB-334867 of 30 mg/kg, based on previous studies
with this compound (Adamantidis et al., 2007; Haynes et al., 2000, 2002;
Rodgers et al., 2001). Eight mice per group were used, which were put into
the beam-break cages at 0900 hr (10 hr before gavage). AA or vehicle gavage
was performed as described above. SB-334867 (in vehicle, 0.9% NaCl 10%
DMSO), or vehicle alone, was injected i.p. (injected volume = 10 ml/g) at the
same time as gavage. Total x axis locomotor activity was grouped in 2 hr bins.
Assays of orx/hcrt Activity after Central Administration
of Amino Acids
Intrahypothalamic Infusions
Mice were housed in individual Plexiglas recording cages in temperature
(22C ± 1C) and humidity (40%–60%) controlled recording chambers
Neuron
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ments) under a 12 hr/12 hr light/dark cycle (lights on at 0700 hr). Food
and water were available ad libitum. Animals were implanted with a 26G
bilateral cannula (Plastics One) under ketamine/xylazine anesthesia (80 and
16 mg/kg, i.p., respectively). The cannula was placed above the lateral hypo-
thalamus (anteroposterior, 1.8 mm; mediolateral, 0.8 mm; dorsoventral;
4.5 mm) according to the brain atlas (Franklin and Paxinos, 2008) and affixed
to the skull with C&B metabond (Parkell, Edgewood, NY) and dental acrylic.
Mice were allowed to recover for 10 days and were then habituated for
5 days to infusion procedure before the experiment. On the day of experiment,
animals were connected to an internal bilateral cannula. At 1000 hr, vehicle
was infused in the left part of the brain while either L-leucine (5mM) or L-aspar-
agine (5 mM) was infused in the right part of the brain in two separate experi-
ments. In each condition, a total volume of 0.5 ml was injected through
the cannula at a rate of 0.25 ml/min. Internal cannula was maintained in
place for one additional minute to allow liquid diffusion through the brain
tissue. Animals were sacrificed 1 hr after the infusion protocol for immuno-
histochemistry tissue processing.
Immunocytochemistry
We quantified the activation of orx/hcrt neurons after intrahypothalamic infu-
sions of AA using double immunostaining for c-Fos and orx/hcrt. The double
immunostaining was performed on brain sections from wild-type animals as
previously described (Adamantidis et al., 2007). Briefly, mice (n = 4 per condi-
tion) were anesthetized with xylazine/ketamine and perfused transcardially
with physiological saline followed by 4% paraformaldehyde in phosphate-
buffered saline (PBS; pH 7.4), 1 hr after vehicle or AA infusion. Brains were
postfixed and cryoprotected. Coronal brain sections containing the lateral
hypothalamus were successively incubated in (1) a rabbit antiserum to c-Fos
(1:5000, Calbiochem) in PBS supplemented with 0.3% Triton X-100 (PBST)
and 4% bovine serum albumin (BSA, Sigma) for 1 day at 4C; (2) a biotinylated
antirabbit IgG solution (1:1000, Vector Laboratories) in PBST; and (3) an ABC-
peroxidase solution (1:1000, Vector Laboratories) both for 60 min at room
temperature. Finally, sections were stained using 3,30-diaminobenzidine-4
HCl and Nickel solution (DAB-Ni; Vector Laboratories) in order to obtain dark
purple staining. Four washes in PBST were performed between each step.
The c-Fos-stained sections were incubated in a goat antiserum to orx/hcrt
(1:4000; Santa Cruz) in PBST/BSA 4% for 2 days at 4C. Amplification steps
were similar to those described above but the final step was performed in
DAB solution without nickel in order to obtain brown staining. Finally, the
sections were mounted on slides, dried, and coverslipped with permaslip.
Orx/hcrt-positive and orx/hcrt+c-Fos-positive neurons were counted by an
investigator blind to experimental conditions, within at least six coronal
sections per animal evenly spaced throughout the rostrocaudal extent of
the lateral hypothalamus (Bregma 1.06 to 2.14) to avoid rostrocaudal
bias. Colocalization of c-Fos and orx/hcrt immunostaining was detected
using a high magnification objective. No significant differences were found
in the number of c-Fos-positive orx/hcrt neurons between vehicle injection
experiments.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and one table and can be found
with this article online at doi:10.1016/j.neuron.2011.08.027.
ACKNOWLEDGMENTS
This work was funded primarily by the European Research Council (ERC FP7
Starting Grant to D.B.). M.M.K. was also supported by Osk. Huttunen Founda-
tion (PhD studentship). L.d.L. was supported by the NIH, and A.A. by the NIH,
FRS-FNRS, and NARSAD. L.F. was funded by the Lundbeck Foundation and
the MRC in UK and Denmark. We thank Dr. Peter Voshol and Sylvia Osborn of
mouse core facilities at Medical Research Council Centre for Obesity and
Related Metabolic Diseases (MRC CORD) for assisting with experiments in
Figure 2. MMK performed and designed most experiments, analyzed data,
and contributed to writing of the paper. J.A.-S. contributed to the experiments
shown in Figure 2. A.A. and L.d.L. contributed to the experiments shown inFigure 3. L.F. and L.T.J. created and provided orx/hcrt-eGFP mice used in
the project. DB conceived the idea, obtained funding, coordinated the project,
and wrote the paper.
Accepted: August 22, 2011
Published: November 16, 2011
REFERENCES
Adamantidis, A.R., Zhang, F., Aravanis, A.M., Deisseroth, K., and de Lecea, L.
(2007). Neural substrates of awakening probed with optogenetic control of
hypocretin neurons. Nature 450, 420–424.
Adibi, S.A. (1968). Influence of dietary deprivations on plasma concentration of
free amino acids of man. J. Appl. Physiol. 25, 52–57.
Ashcroft, F.M. (1988). Adenosine 50-triphosphate-sensitive potassium
channels. Annu. Rev. Neurosci. 11, 97–118.
Bali, B., Erde´lyi, F., Szabo´, G., and Kova´cs, K.J. (2005). Visualization of stress-
responsive inhibitory circuits in the GAD65-eGFP transgenic mice. Neurosci.
Lett. 380, 60–65.
Blouet, C., Jo, Y.H., Li, X., and Schwartz, G.J. (2009). Mediobasal hypotha-
lamic leucine sensing regulates food intake through activation of a hypothal-
amus-brainstem circuit. J. Neurosci. 29, 8302–8311.
Boutrel, B., Kenny, P.J., Specio, S.E., Martin-Fardon, R., Markou, A., Koob,
G.F., and de Lecea, L. (2005). Role for hypocretin in mediating stress-induced
reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA 102,
19168–19173.
Brundin, L., Bjo¨rkqvist, M., Peterse´n, A., and Tra¨skman-Bendz, L. (2007).
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major
depressive disorder. Eur. Neuropsychopharmacol. 17, 573–579.
Burdakov, D., Jensen, L.T., Alexopoulos, H., Williams, R.H., Fearon, I.M.,
O’Kelly, I., Gerasimenko, O., Fugger, L., and Verkhratsky, A. (2006).
Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose.
Neuron 50, 711–722.
Cai, X.J., Evans, M.L., Lister, C.A., Leslie, R.A., Arch, J.R., Wilson, S., and
Williams, G. (2001). Hypoglycemia activates orexin neurons and selectively
increases hypothalamic orexin-B levels: responses inhibited by feeding and
possibly mediated by the nucleus of the solitary tract. Diabetes 50, 105–112.
Choi, Y.H., Chang, N., and Anderson, G.H. (1999). An intragastric amino acid
mixture influences extracellular amino acid profiles in the lateral hypothalamic
area of freely moving rats. Can. J. Physiol. Pharmacol. 77, 827–834.
Choi, Y.H., Chang, N., Fletcher, P.J., and Anderson, G.H. (2000). Dietary
protein content affects the profiles of extracellular amino acids in the medial
preoptic area of freely moving rats. Life Sci. 66, 1105–1118.
Cota, D., Proulx, K., Smith, K.A., Kozma, S.C., Thomas, G., Woods, S.C., and
Seeley, R.J. (2006). Hypothalamic mTOR signaling regulates food intake.
Science 312, 927–930.
Cruz, F., Villalba, M., Garcı´a-Espinosa, M.A., Ballesteros, P., Bogo´nez, E.,
Satru´stegui, J., and Cerda´n, S. (2001). Intracellular compartmentation of
pyruvate in primary cultures of cortical neurons as detected by (13)C NMR
spectroscopy with multiple (13)C labels. J. Neurosci. Res. 66, 771–781.
Currie, P.J., Chang, N., Luo, S., and Anderson, G.H. (1995). Microdialysis as
a tool to measure dietary and regional effects on the complete profile of extra-
cellular amino acids in the hypothalamus of rats. Life Sci. 57, 1911–1923.
de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E.,
Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., 2nd., et al.
(1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory
activity. Proc. Natl. Acad. Sci. USA 95, 322–327.
de Lecea, L., Jones, B.E., Boutrel, B., Borgland, S.L., Nishino, S., Bubser, M.,
and DiLeone, R. (2006). Addiction and arousal: alternative roles of hypotha-
lamic peptides. J. Neurosci. 26, 10372–10375.
Diano, S., Horvath, B., Urbanski, H.F., Sotonyi, P., and Horvath, T.L. (2003).
Fasting activates the nonhuman primate hypocretin (orexin) system and its
postsynaptic targets. Endocrinology 144, 3774–3778.Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 627
Neuron
Hypothalamic Integration of Macronutrient SignalsEstabrooke, I.V., McCarthy, M.T., Ko, E., Chou, T.C., Chemelli, R.M.,
Yanagisawa, M., Saper, C.B., and Scammell, T.E. (2001). Fos expression in
orexin neurons varies with behavioral state. J. Neurosci. 21, 1656–1662.
Felig, P., Owen, O.E., Wahren, J., and Cahill, G.F., Jr. (1969). Amino acid
metabolism during prolonged starvation. J. Clin. Invest. 48, 584–594.
Fischer, K., Colombani, P.C., Langhans, W., and Wenk, C. (2002).
Carbohydrate to protein ratio in food and cognitive performance in the
morning. Physiol. Behav. 75, 411–423.
Flier, J.S. (2004). Obesity wars: molecular progress confronts an expanding
epidemic. Cell 116, 337–350.
Franklin, K.B., and Paxinos, G. (2008). The mouse brain in stereotaxic coordi-
nates (Boston: Elsevier Academic Press).
Gietzen, D.W., and Rogers, Q.R. (2006). Nutritional homeostasis and
indispensable amino acid sensing: a new solution to an old puzzle. Trends
Neurosci. 29, 91–99.
Hagan, J.J., Leslie, R.A., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S.,
Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P., et al. (1999). Orexin
A activates locus coeruleus cell firing and increases arousal in the rat. Proc.
Natl. Acad. Sci. USA 96, 10911–10916.
Hao, S., Sharp, J.W., Ross-Inta, C.M., McDaniel, B.J., Anthony, T.G., Wek,
R.C., Cavener, D.R., McGrath, B.C., Rudell, J.B., Koehnle, T.J., and Gietzen,
D.W. (2005). Uncharged tRNA and sensing of amino acid deficiency in
mammalian piriform cortex. Science 307, 1776–1778.
Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton,
C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M., and Sakurai, T.
(2001). Genetic ablation of orexin neurons in mice results in narcolepsy, hypo-
phagia, and obesity. Neuron 30, 345–354.
Harris, G.C., Wimmer, M., and Aston-Jones, G. (2005). A role for lateral hypo-
thalamic orexin neurons in reward seeking. Nature 437, 556–559.
Haynes, A.C., Jackson, B., Chapman, H., Tadayyon, M., Johns, A., Porter,
R.A., and Arch, J.R. (2000). A selective orexin-1 receptor antagonist reduces
food consumption in male and female rats. Regul. Pept. 96, 45–51.
Haynes, A.C., Chapman, H., Taylor, C., Moore, G.B., Cawthorne, M.A.,
Tadayyon, M., Clapham, J.C., and Arch, J.R. (2002). Anorectic, thermogenic
and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob
mice. Regul. Pept. 104, 153–159.
Ito, N., Yabe, T., Gamo, Y., Nagai, T., Oikawa, T., Yamada, H., and Hanawa, T.
(2008). I.c.v. administration of orexin-A induces an antidepressive-like effect
through hippocampal cell proliferation. Neuroscience 157, 720–732.
Karnani, M., and Burdakov, D. (2011). Multiple hypothalamic circuits sense
and regulate glucose levels. Am. J. Physiol. Regul. Integr. Comp. Physiol.
300, R47–R55.
Karnani, M.M., Venner, A., Jensen, L.T., Fugger, L., and Burdakov, D. (2010).
Direct and indirect control of orexin/hypocretin neurons by glycine receptors.
J. Physiol. 589, 639–651.
Kiyashchenko, L.I., Mileykovskiy, B.Y., Maidment, N., Lam, H.A., Wu, M.F.,
John, J., Peever, J., and Siegel, J.M. (2002). Release of hypocretin (orexin)
during waking and sleep states. J. Neurosci. 22, 5282–5286.
Kohsaka, A., Laposky, A.D., Ramsey, K.M., Estrada, C., Joshu, C., Kobayashi,
Y., Turek, F.W., and Bass, J. (2007). High-fat diet disrupts behavioral and
molecular circadian rhythms in mice. Cell Metab. 6, 414–421.
Komaki, G., Matsumoto, Y., Nishikata, H., Kawai, K., Nozaki, T., Takii, M.,
Sogawa, H., and Kubo, C. (2001). Orexin-A and leptin change inversely in
fasting non-obese subjects. Eur. J. Endocrinol. 144, 645–651.
Kuwaki, T. (2011). Orexin links emotional stress to autonomic functions. Auton.
Neurosci. 161, 20–27.
Lam, T.K., Schwartz, G.J., and Rossetti, L. (2005). Hypothalamic sensing of
fatty acids. Nat. Neurosci. 8, 579–584.
Levin, B.E., Routh, V.H., Kang, L., Sanders, N.M., and Dunn-Meynell, A.A.
(2004). Neuronal glucosensing: what do we know after 50 years? Diabetes
53, 2521–2528.628 Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc.Lo´pez-Bendito, G., Sturgess, K., Erde´lyi, F., Szabo´, G., Molna´r, Z., and
Paulsen, O. (2004). Preferential origin and layer destination of GAD65-GFP
cortical interneurons. Cereb. Cortex 14, 1122–1133.
Mackenzie, B., and Erickson, J.D. (2004). Sodium-coupled neutral amino acid
(System N/A) transporters of the SLC38 gene family. Pflugers Arch. 447,
784–795.
Mackenzie, B., Scha¨fer, M.K., Erickson, J.D., Hediger, M.A., Weihe, E., and
Varoqui, H. (2003). Functional properties and cellular distribution of the system
A glutamine transporter SNAT1 support specialized roles in central neurons.
J. Biol. Chem. 278, 23720–23730.
Meuth, S.G., Budde, T., Kanyshkova, T., Broicher, T., Munsch, T., and Pape,
H.C. (2003). Contribution of TWIK-related acid-sensitive K+ channel 1
(TASK1) and TASK3 channels to the control of activity modes in thalamocort-
ical neurons. J. Neurosci. 23, 6460–6469.
Mieda, M., Williams, S.C., Sinton, C.M., Richardson, J.A., Sakurai, T., and
Yanagisawa, M. (2004). Orexin neurons function in an efferent pathway of
a food-entrainable circadian oscillator in eliciting food-anticipatory activity
and wakefulness. J. Neurosci. 24, 10493–10501.
Mileykovskiy, B.Y., Kiyashchenko, L.I., and Siegel, J.M. (2005). Behavioral
correlates of activity in identified hypocretin/orexin neurons. Neuron 46,
787–798.
Nishimura, F., Nishihara, M., Mori, M., Torii, K., and Takahashi, M. (1995).
Excitability of neurons in the ventromedial nucleus in rat hypothalamic slices:
modulation by amino acids at cerebrospinal fluid levels. Brain Res. 691,
217–222.
Nishino, S., Ripley, B., Overeem, S., Lammers, G.J., and Mignot, E. (2000).
Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40.
Nishino, S., Ripley, B., Overeem, S., Nevsimalova, S., Lammers, G.J.,
Vankova, J., Okun, M., Rogers, W., Brooks, S., and Mignot, E. (2001). Low
cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in
human narcolepsy. Ann. Neurol. 50, 381–388.
Oldendorf, W.H., and Szabo, J. (1976). Amino acid assignment to one of three
blood-brain barrier amino acid carriers. Am. J. Physiol. 230, 94–98.
Oomura, Y., Nakamura, T., Sugimori, M., and Yamada, Y. (1975). Effect of
free fatty acid on the rat lateral hypothalamic neurons. Physiol. Behav. 14,
483–486.
Perkins, K.L. (2006). Cell-attached voltage-clamp and current-clamp
recording and stimulation techniques in brain slices. J. Neurosci. Methods
154, 1–18.
Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe,
J.G., and Kilduff, T.S. (1998). Neurons containing hypocretin (orexin) project to
multiple neuronal systems. J. Neurosci. 18, 9996–10015.
Phillis, J.W., Song, D., and O’Regan, M.H. (1999). Melittin enhances amino
acid and free fatty acid release from the in vivo cerebral cortex. Brain Res.
847, 270–275.
Rodgers, R.J., Halford, J.C., Nunes de Souza, R.L., Canto de Souza, A.L.,
Piper, D.C., Arch, J.R., Upton, N., Porter, R.A., Johns, A., and Blundell, J.E.
(2001). SB-334867, a selective orexin-1 receptor antagonist, enhances
behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
Eur. J. Neurosci. 13, 1444–1452.
Routh, V.H. (2002). Glucose-sensing neurons: are they physiologically rele-
vant? Physiol. Behav. 76, 403–413.
Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep
and wakefulness. Nat. Rev. Neurosci. 8, 171–181.
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H.,
Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., et al. (1998).
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G
protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585.
Silver, I.A., and Erecinska, M. (1994). Extracellular glucose concentration in
mammalian brain: continuous monitoring of changes during increased
neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and
hyperglycemic animals. J. Neurosci. 14, 5068–5076.
Neuron
Hypothalamic Integration of Macronutrient SignalsSmart, D., Sabido-David, C., Brough, S.J., Jewitt, F., Johns, A., Porter, R.A.,
and Jerman, J.C. (2001). SB-334867-A: the first selective orexin-1 receptor
antagonist. Br. J. Pharmacol. 132, 1179–1182.
Spring, B., Maller, O., Wurtman, J., Digman, L., and Cozolino, L. (1982-1983).
Effects of protein and carbohydrate meals on mood and performance: interac-
tions with sex and age. J. Psychiatr. Res. 17, 155–167.
Spring, B., Chiodo, J., and Bowen, D.J. (1987). Carbohydrates, tryptophan,
and behavior: a methodological review. Psychol. Bull. 102, 234–256.
Stryer, L. (1999). Biochemistry (New York: W.H.Freeman and Company).
Suzuki, M., Beuckmann, C.T., Shikata, K., Ogura, H., and Sawai, T. (2005).
Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like
behavior. Brain Res. 1044, 116–121.
Tarasenko, A.S., Linetska, M.V., Storchak, L.G., and Himmelreich, N.H. (2006).
Effectiveness of extracellular lactate/pyruvate for sustaining synaptic
vesicle proton gradient generation and vesicular accumulation of GABA.
J. Neurochem. 99, 787–796.
Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S.,
Aldrich, M., Cornford, M., and Siegel, J.M. (2000). Reduced number of hypo-
cretin neurons in human narcolepsy. Neuron 27, 469–474.
Wang, R., Cruciani-Guglielmacci, C., Migrenne, S., Magnan, C., Cotero, V.E.,
and Routh, V.H. (2006). Effects of oleic acid on distinct populations of neurons
in the hypothalamic arcuate nucleus are dependent on extracellular glucose
levels. J. Neurophysiol. 95, 1491–1498.White, B.D., Du, F., and Higginbotham, D.A. (2003). Low dietary protein is
associated with an increase in food intake and a decrease in the in vitro release
of radiolabeled glutamate and GABA from the lateral hypothalamus. Nutr.
Neurosci. 6, 361–367.
Williams, R.H., Morton, A.J., and Burdakov, D. (2011). Paradoxical function of
orexin/hypocretin circuits in a mouse model of Huntington’s disease.
Neurobiol. Dis. 42, 438–445.
Williams, R.H., Jensen, L.T., Verkhratsky, A., Fugger, L., and Burdakov, D.
(2007). Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl.
Acad. Sci. USA 104, 10685–10690.
Williams, R.H., Alexopoulos, H., Jensen, L.T., Fugger, L., and Burdakov, D.
(2008). Adaptive sugar sensors in hypothalamic feeding circuits. Proc. Natl.
Acad. Sci. USA 105, 11975–11980.
Winsky-Sommerer, R., Yamanaka, A., Diano, S., Borok, E., Roberts, A.J.,
Sakurai, T., Kilduff, T.S., Horvath, T.L., and de Lecea, L. (2004). Interaction
between the corticotropin-releasing factor system and hypocretins (orexins):
a novel circuit mediating stress response. J. Neurosci. 24, 11439–11448.
Yamanaka, A., Beuckmann, C.T., Willie, J.T., Hara, J., Tsujino, N., Mieda, M.,
Tominaga, M., Yagami, K., Sugiyama, F., Goto, K., et al. (2003). Hypothalamic
orexin neurons regulate arousal according to energy balance in mice. Neuron
38, 701–713.Neuron 72, 616–629, November 17, 2011 ª2011 Elsevier Inc. 629
